ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$CELC:NASDAQ · CELCUITY INC

Sector: health

Conviction from: NASDAQ

52-week range: 44.42151.02

Targeted-oncology drug developer

3 tracked filer(s) hold this · 2 opened, 1 added, 0 trimmed in 30-JUN-2026

Aggregate 13FScore 71 — mean of 3 scored holder(s) · buyers (new/add) avg 71. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Howard Marks / Oaktree70New buy6,250,000$7,133,7500.1%
Paul Tudor Jones / Tudor63New buy9,800$1,025,2760.0%
Steve Cohen / Point7280Added +103%650,916$68,098,8320.1%

Beyond 13F — activists, insiders, politicians & research

Activist 13D filings daily digest →

FiledFormActivist% of classConviction
2026-03-24SCHEDULE 13D/ABAKER BROS. ADVISORS LP20.0%Highfiling
2026-03-09SCHEDULE 13D/AGrowth Equity Opportunities 18 VGE, LLC4.9%Lowfiling
2026-01-16SCHEDULE 13D/AGrowth Equity Opportunities 18 VGE, LLC6.3%Medfiling

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.